Sign up
Log in
FMC Corp. Announces Submission Of Regulatory Dossier For Rimisoxafen To Brazilian Regulatory Authorities
Share
Listen to the news

Second global filing advances rimisoxafen as a novel weed control solution for Brazil's more than 70 million hectares of corn and soybeans

FMC Corporation (NYSE:FMC), a leading global agricultural sciences company, today announced the submission of the regulatory dossier for rimisoxafen to Brazilian regulatory authorities. The filing marks the second global regulatory submission for rimisoxafen, the first and only dual mode of action herbicide, following FMC's submission to the U.S. Environmental Protection Agency in July 2026.

Rimisoxafen is the third novel herbicide active ingredient FMC has advanced to regulatory submission in Brazil, following Isoflex™ active and Dodhylex™ active. Together, these submissions reflect the depth and productivity of FMC's research and development pipeline and the company's commitment to advancing next-generation crop protection solutions through the regulatory process.

Formulated product submissions for rimisoxafen are expected to follow as the regulatory process advances in Brazil. Timing and outcomes remain subject to regulatory review and approval. Rimisoxafen is not registered for sale or use in Brazil or any other country. No offer for sale, sale or use of this product is permitted prior to receipt of all required regulatory approvals.


 

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.